Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Robert Baker currently holds 161,041 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Robert Baker has been a net buyer of PGNX stock. They have purchased $275.9K and sold $28.2K worth of shares.
Mark Robert Baker's most recent insider trade was on Mar 27, 2013, when they purchased 50 shares at $5.34 per share.
Mark Robert Baker serves as Executive at PROGENICS PHARMACEUTICALS INC (PGNX). They have executed 110 insider transactions totaling $304.0K over their tenure at the company.
Mark Robert Baker holds the position of Executive at PROGENICS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Mark Robert Baker has shown a buying trading pattern, with $275.9K in total purchases and $28.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Robert Baker was on Nov 16, 2012, when they purchased $90.6K worth of PGNX shares. This transaction involved 49,793 shares at $1.82 per share.
Mark Robert Baker currently owns 161,041 shares of PROGENICS PHARMACEUTICALS INC (PGNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Robert Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Robert Baker has 110 Form 4 filings on record as an insider at PROGENICS PHARMACEUTICALS INC.
Set alerts for Mark Robert Baker and 40,000+ other insiders.